Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial
<br><strong>Background: </strong>Cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection continue to rise in the Arabian Peninsula 7 years after it was first described in Saudi Arabia. MERS-CoV poses a significant risk to public health security because of an abse...
Glavni autori: | Folegatti, PM, Bittaye, M, Flaxman, A, Lopez, FR, Bellamy, D, Kupke, A, Mair, C, Makinson, R, Sheridan, J, Rohde, C, Halwe, S, Jeong, Y, Park, Y-S, Kim, J-O, Song, M, Boyd, A, Tran, N, Silman, D, Poulton, I, Datoo, M, Marshal, J, Themistocleous, Y, Lawrie, A, Roberts, R, Berrie, E, Becker, S, Lambe, T, Hill, A, Ewer, K, Gilbert, S |
---|---|
Format: | Journal article |
Jezik: | English |
Izdano: |
Elsevier
2020
|
Slični predmeti
-
Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial
od: Folegatti, PM, i dr.
Izdano: (2020) -
A single dose of ChAdOx1 Chik vaccine induces neutralising antibodies against four chikungunya virus lineages in a phase 1 clinical trial
od: Folegatti, P, i dr.
Izdano: (2021) -
A three-antigen Plasmodium falciparum DNA prime—Adenovirus boost malaria vaccine regimen is superior to a two-antigen regimen and protects against controlled human malaria infection in healthy malaria-naïve adults
od: Sklar, MJ, i dr.
Izdano: (2021) -
Safety and immunogenicity of adenovirus and poxvirus vectored vaccines against a Mycobacterium avium complex subspecies
od: Folegatti, P, i dr.
Izdano: (2021) -
Deep immune phenotyping and single-cell transcriptomics allow identification of circulating TRM-like cells which correlate with liver-stage immunity and vaccine-induced protection from malaria
od: Noe, A, i dr.
Izdano: (2022)